Latest News

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Housing and Urban Development Corporation Limited's ( NSE:HUDCO ) investors are due to receive a payment of ₹1.15 per...

Samay Project Services' (NSE:SAMAY) stock is up by a considerable 11% over the past week. Given that stock prices are...

It is hard to get excited after looking at Gem Aromatics' (NSE:GEMAROMA) recent performance, when its stock has...

Apcotex Industries Limited's ( NSE:APCOTEXIND ) investors are due to receive a payment of ₹2.50 per share on 28th of...

Key Insights Given the large stake in the stock by institutions, Swiggy's stock price might be vulnerable to their...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

APAR Industries Limited ( NSE:APARINDS ) just released its quarterly report and things are looking bullish. APAR...

Key Insights Insiders appear to have a vested interest in Wanguo Gold Group's growth, as seen by their sizeable...

It's shaping up to be a tough period for Heritage Foods Limited ( NSE:HERITGFOOD ), which a week ago released some...

Key Insights Institutions' substantial holdings in Aptus Value Housing Finance India implies that they have significant...

Key Insights Rishabh Instruments' significant insider ownership suggests inherent interests in company's expansion 70...

Meidensha (TSE:6508) has reported Q3 2026 revenue of ¥72.7 billion and basic EPS of ¥167.77, with trailing twelve month basic EPS at ¥489.22. The company has seen revenue move from ¥70.98 billion in Q3 2025 to ¥72.7 billion in Q3 2026, while quarterly basic EPS shifted from ¥84.58 a year ago to ¥167.77 most recently. This sets up a results season in which investors are likely to pay close attention to how net income of ¥7,611 million translates into the quality and resilience of margins. See...

Wheels India Limited ( NSE:WHEELS ) stock is about to trade ex-dividend in 3 days. The ex-dividend date generally...

Visa (V) just posted fiscal first quarter results that beat expectations, with net revenue up 15% and payments volume near US$4t, while also pointing to more moderate growth in the coming quarter. See our latest analysis for Visa. Despite the strong quarter and fresh buyback and dividend activity, Visa's recent share price performance has cooled, with a 30 day share price return of 8.23% and a year to date share price return of 7.11%. At the same time, the 1 year total shareholder return of...

Nihon M&A Center Holdings (TSE:2127) has reported a busy quarter, with Q3 2026 revenue at ¥15.2b and basic EPS of ¥14.53, while trailing 12 month EPS is ¥44.65 on revenue of ¥52.0b. The company’s quarterly revenue has moved from ¥11.3b in Q3 2025 to ¥15.2b in Q3 2026, with basic EPS over that span shifting from ¥9.68 to ¥14.53. This leaves investors to weigh the high reported margins against the sustainability of the recent earnings strength. See our full analysis for Nihon M&A Center...

Niterra (TSE:5334) has just posted its Q3 2026 numbers, with revenue of ¥174.9b and basic EPS of ¥150.45, giving investors another clean datapoint on how the year is shaping up. The company has seen quarterly revenue move from ¥161.1b in Q3 2025 to ¥174.9b in Q3 2026, while basic EPS has shifted from ¥121.20 to ¥150.45 over the same period. Margins, already in focus thanks to a 14.7% net profit margin over the past year, remain central to the story. See our full analysis for Niterra. With the...

Adani Total Gas (NSE:ATGL) has had a rough three months with its share price down 17%. However, stock prices are...

Goldman Sachs recently upgraded BioNTech SE to Buy, highlighting the company’s position in next-generation immuno-oncology and antibody-drug conjugates, with key oncology data expected in 2026. This endorsement reinforces BioNTech’s shift from its Covid-focused profile toward building a broader oncology franchise powered by its mRNA and antibody platforms. Next, we’ll examine how Goldman Sachs’ confidence in BioNTech’s oncology pipeline could influence the company’s long-term investment...

Asahi Yukizai (TSE:4216) opened Q3 2026 with revenue of ¥19.8 billion and basic EPS of ¥53.98, alongside trailing twelve month revenue of ¥81.7 billion and EPS of ¥296.12 that frame how the latest quarter sits within the year to date. The company has seen quarterly revenue move from ¥21.5 billion and basic EPS of ¥105.35 in Q2 2025 to ¥19.8 billion and EPS of ¥53.98 in Q3 2026. Over the same period, trailing twelve month EPS shifted from ¥509.90 to ¥296.12. For investors, the immediate focus...

Q3 2026 earnings snapshot and what it means for the narrative Takebishi (TSE:7510) has posted Q3 2026 revenue of ¥29.7 billion and basic EPS of ¥56.90, with trailing twelve month EPS at ¥176.97 against revenue of ¥110.7 billion and net income of ¥2.8 billion. The company has seen quarterly revenue move from ¥24.6 billion in Q3 2025 to ¥29.7 billion in Q3 2026, while basic EPS shifted from ¥54.11 to ¥56.90 over the same period. This sets up a picture where investors are watching how...

With a price-to-earnings (or "P/E") ratio of 14.1x D-Link (India) Limited ( NSE:DLINKINDIA ) may be sending bullish...

Investors in LMW Limited ( NSE:LMW ) had a good week, as its shares rose 5.1% to close at ₹14,920 following the release...

Enova International recently reported past fourth-quarter and full-year 2025 results showing revenue of US$501.89 million for the quarter and US$1.83 billion for the year, with net income rising to US$78.98 million and US$308.39 million respectively alongside higher earnings per share. Investors also learned that Enova is combining continued originations growth, an active share repurchase program that has retired almost 10% of shares, and a planned acquisition of Grasshopper Bank intended to...